Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ICX-Implant System

K-Number: K231566 · 2024-09-05

Decision Date2024-09-05
Product CodeDZE
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

ICX-Implant System is a medical device manufactured by Medentis Medical GmbH. It received FDA 510(k) clearance on 2024-09-05 under approval number K231566. The device is classified under product code DZE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ICX-Implant System?

ICX-Implant System is a medical device that received FDA 510(k) clearance on 2024-09-05. It is manufactured by Medentis Medical GmbH. The 510(k) number is K231566.

When was ICX-Implant System approved by the FDA?

ICX-Implant System received FDA 510(k) clearance on 2024-09-05, under approval number K231566.

What company makes ICX-Implant System?

ICX-Implant System is manufactured by Medentis Medical GmbH.

What is the FDA product code for ICX-Implant System?

The FDA product code for ICX-Implant System is DZE.

Related Clinical Trials

Related PubMed Literature

Related Devices (Code: DZE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.